Health Canada has provided new clarity on how topical products containing human-derived exosomes, human extracellular vesicles (EVs), or human cell-conditioned media should be classified in Canada. In its Final Notice published April 10, 2026, Health Canada confirmed that these substances are not considered “inherent drugs” based on the evidence currently available. This means they may...
